These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 17028027

  • 1. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
    Tojo K, Sekijima Y, Kelly JW, Ikeda S.
    Neurosci Res; 2006 Dec; 56(4):441-9. PubMed ID: 17028027
    [Abstract] [Full Text] [Related]

  • 2. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.
    Sekijima Y, Dendle MA, Kelly JW.
    Amyloid; 2006 Dec; 13(4):236-49. PubMed ID: 17107884
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
    Green NS, Palaninathan SK, Sacchettini JC, Kelly JW.
    J Am Chem Soc; 2003 Nov 05; 125(44):13404-14. PubMed ID: 14583036
    [Abstract] [Full Text] [Related]

  • 4. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
    Adamski-Werner SL, Palaninathan SK, Sacchettini JC, Kelly JW.
    J Med Chem; 2004 Jan 15; 47(2):355-74. PubMed ID: 14711308
    [Abstract] [Full Text] [Related]

  • 5. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
    Almeida MR, Macedo B, Cardoso I, Alves I, Valencia G, Arsequell G, Planas A, Saraiva MJ.
    Biochem J; 2004 Jul 15; 381(Pt 2):351-6. PubMed ID: 15080795
    [Abstract] [Full Text] [Related]

  • 6. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.
    Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, Kelly JW.
    Acc Chem Res; 2005 Dec 15; 38(12):911-21. PubMed ID: 16359163
    [Abstract] [Full Text] [Related]

  • 7. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
    Sato T, Ando Y, Susuki S, Mikami F, Ikemizu S, Nakamura M, Suhr O, Anraku M, Kai T, Suico MA, Shuto T, Mizuguchi M, Yamagata Y, Kai H.
    FEBS Lett; 2006 Jan 23; 580(2):491-6. PubMed ID: 16386248
    [Abstract] [Full Text] [Related]

  • 8. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
    Sekijima Y, Dendle MT, Wiseman RL, White JT, D'Haeze W, Kelly JW.
    Amyloid; 2006 Jun 23; 13(2):57-66. PubMed ID: 16911959
    [Abstract] [Full Text] [Related]

  • 9. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?
    Hammarström P, Sekijima Y, White JT, Wiseman RL, Lim A, Costello CE, Altland K, Garzuly F, Budka H, Kelly JW.
    Biochemistry; 2003 Jun 10; 42(22):6656-63. PubMed ID: 12779320
    [Abstract] [Full Text] [Related]

  • 10. Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis.
    Wiseman RL, Green NS, Kelly JW.
    Biochemistry; 2005 Jun 28; 44(25):9265-74. PubMed ID: 15966751
    [Abstract] [Full Text] [Related]

  • 11. Clusterin regulates transthyretin amyloidosis.
    Lee KW, Lee DH, Son H, Kim YS, Park JY, Roh GS, Kim HJ, Kang SS, Cho GJ, Choi WS.
    Biochem Biophys Res Commun; 2009 Oct 16; 388(2):256-60. PubMed ID: 19664600
    [Abstract] [Full Text] [Related]

  • 12. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type.
    Saraiva MJ, Costa PP, Goodman DS.
    J Lab Clin Med; 1983 Oct 16; 102(4):590-603. PubMed ID: 6311926
    [Abstract] [Full Text] [Related]

  • 13. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants.
    Miller SR, Sekijima Y, Kelly JW.
    Lab Invest; 2004 May 16; 84(5):545-52. PubMed ID: 14968122
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic strategy for familial amyloid polyneuropathy (FAP)].
    Ikeda S.
    Rinsho Shinkeigaku; 2009 Nov 16; 49(11):953-5. PubMed ID: 20030258
    [Abstract] [Full Text] [Related]

  • 15. Kinetic stabilization of an oligomeric protein by a single ligand binding event.
    Wiseman RL, Johnson SM, Kelker MS, Foss T, Wilson IA, Kelly JW.
    J Am Chem Soc; 2005 Apr 20; 127(15):5540-51. PubMed ID: 15826192
    [Abstract] [Full Text] [Related]

  • 16. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y.
    Amyloid; 2003 Aug 20; 10 Suppl 1():55-66. PubMed ID: 14640043
    [Abstract] [Full Text] [Related]

  • 17. Cooperative stabilization of transthyretin by clusterin and diflunisal.
    Greene MJ, Klimtchuk ES, Seldin DC, Berk JL, Connors LH.
    Biochemistry; 2015 Jan 20; 54(2):268-78. PubMed ID: 25478940
    [Abstract] [Full Text] [Related]

  • 18. Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis.
    Foss TR, Kelker MS, Wiseman RL, Wilson IA, Kelly JW.
    J Mol Biol; 2005 Apr 08; 347(4):841-54. PubMed ID: 15769474
    [Abstract] [Full Text] [Related]

  • 19. Recent progress in the understanding and treatment of transthyretin amyloidosis.
    Sekijima Y.
    J Clin Pharm Ther; 2014 Jun 08; 39(3):225-33. PubMed ID: 24749898
    [Abstract] [Full Text] [Related]

  • 20. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
    Liang Y, Ore MO, Morin S, Wilson DJ.
    Biochemistry; 2012 Apr 24; 51(16):3523-30. PubMed ID: 22482799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.